DNA
Ginkgo Bioworks Holdings, Inc.
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Ginkgo Bioworks (DNA) Stock: Buy, Sell, or Hold?
$10.23
-0.02 (-0.20%)
âŧ
5d:
+2.71%
30d:
-11.27%
90d:
+50.66%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 05, 2026
0d
Protect DNA Gains
Updated Nov 12, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (72%)
Quality Score
50/100
Position
SLIGHTLY LOW
30-Day Fair Range
$10.03 â $12.52
Position: SLIGHTLY LOW
Forward P/E & Valuation
-3.5x
Next 12M consensus est.
Wall Street Target
$8.00
-21.8% vs target
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$9.28 / $13.12
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: DNA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When DNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: DNA is currently trading at $10.23, which is considered slightly low relative to its 30-day fair value range of $10.03 to $12.52.
Technical Outlook: Technically, DNA is in a strong uptrend. Immediate support is located at $9.28, while resistance sits at $13.12.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. However, the stock is trading significantly above the average Wall Street target of $8.00. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DNA is in a strong uptrend. Immediate support is located at $9.28, while resistance sits at $13.12.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. However, the stock is trading significantly above the average Wall Street target of $8.00. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$10.03 -
$12.52
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.1%
Trading Range & Key Levels
30-Day Trading Range
$10.03 -
$12.52
Current vs Trading Range
SLIGHTLY LOW
Support Level
$9.28
Resistance Level
$13.12
Current Trend
Strong Uptrend
Technical data as of
Nov 12, 2026
Protect Your Profits
Holding DNA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 21.8% above Wall St target ($8.00)
- WARNING: Composite score 50/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-3.53
Wall Street Target
$8.00
(-21.8%)
Revenue Growth (YoY)
-5.7%
Profit Margin
-192.0%
Share DNA Analysis
Share this live DNA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (DNA)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
Ginkgo Bioworks ($DNA) reported Q3 2026 earnings with improved net loss and Adjusted EBITDA, attributable to cost cuts and first autonomous lab sale. The company also added new contracts and partnerships, showcasing technology validity.
Key Retail Themes:
Cost reductions and first big sale
Technology validation through new contracts and partnerships
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 8:13 PM ET
Data refreshes hourly during market hours. Next update: 9:13 PM
Data refreshes hourly during market hours. Next update: 9:13 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DNA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron PharmaceuticalâĻ |
BUY
28 analysts |
$978 | 32 SELL |
|
PRAX
Praxis Precision MedicinâĻ |
STRONG BUY
21 analysts |
$650 | 32 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$296 | 24 SELL |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
17 analysts |
$34 | 49 HOLD |
|
ACAD
ACADIA Pharmaceuticals IâĻ |
STRONG BUY
20 analysts |
$31 | 48 HOLD |
Advanced DNA Option Strategies
Professional options setups generated by AI based on today's DNA price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive DNA Research Pages
